DOI 10.1007/s10072-025-08803-6
Clinical and genetic spectrum of L-dopa responsive dystonia: insights from seven Egyptian cases.
Аннотация
BACKGROUND
Dopa-responsive dystonia (DRD) encompasses a group of treatable movement disorders with significant clinical and genetic heterogeneity. Despite being treatable, DRD is often misdiagnosed, leading to delays in therapy.
METHODS
This retrospective study aims to describe the clinical and genetic features of seven Egyptian patients from four unrelated families with confirmed DRD. Medical records were reviewed to document clinical data, neuroimaging, and genetic testing.
RESULTS
We identified six patients with Tyrosine hydroxylase-deficient DRD and one with GTP cyclohydrolase 1 deficiency. The age at onset of initial symptoms ranged from 0.6 to 1.5 years. Universal clinical features included motor delay, weakness, and delayed speech and language development. Neuroimaging findings showed periventricular demyelination in two patients and brain atrophic changes in one. We identified two previously reported variants in the TH gene (c.-70G > A and c.938G > T) and one novel variant in the GCH1 gene (c.343 + 1G > A). All patients, except one, showed a complete response to L-dopa therapy within the first six months of treatment.
CONCLUSION
This first Egyptian cohort highlights DRD as a treatable yet underdiagnosed cause of dystonia in the Middle East. We report a novel GCH1 variant and TH-related type A phenotypes, underscoring the importance of early genetic diagnosis and levodopa therapy.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.